ReP USP - Resultado da busca

Artigo de periodico
Neutralizing antibody responses after a two-dose regimen with BNT162b2, CoronaVac or ChAdOx1-S in Brazil: differential neutralization of SARS-CoV-2 omicron variants (2025)
Daher, Isabela Pazotti ; Almeida, Bianca da Silva ; Souza-Silva, Guilherme Antonio de ; Marques, Rodolfo Ferreira ; Soares, Gustavo Henrique Corrêa ; Andreata-Santos, Robert ; Moretti, Ana ; Silva, Mariângela de Oliveira ; Schuch, Viviane ; Sasahara, Greyce Luri ; Kuramoto, Andréia; Yamamoto, Márcio ; Santos, Keity ; Coelho, Veronica Porto Carreiro de Vasconcellos ; Kalil Filho, Jorge Elias ; Rosa, Daniela Santoro ; Cunha Neto, Edecio ; Ferreira, Luís Carlos de Souza ; Boscardin, Silvia Beatriz
Fonte: Clinical Immunology. Unidades: ICB, FM, FCF
Assuntos: MICROBIOLOGIA, PARASITOLOGIA, VARIAÇÃO GENÉTICA, COVID-19, VACINAS VIRAIS, NEUTRALIZAÇÃO, CORONAVIRUS, VÍRUS DE RNA, INFECÇÕES POR VÍRUS DE RNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DAHER, Isabela Pazotti et al. Neutralizing antibody responses after a two-dose regimen with BNT162b2, CoronaVac or ChAdOx1-S in Brazil: differential neutralization of SARS-CoV-2 omicron variants. Clinical Immunology, v. 276, p. 12 , 2025Tradução . . Disponível em: https://doi.org/10.1016/j.clim.2025.110492. Acesso em: 26 jun. 2025.
APA
Daher, I. P., Almeida, B. da S., Souza-Silva, G. A. de, Marques, R. F., Soares, G. H. C., Andreata-Santos, R., et al. (2025). Neutralizing antibody responses after a two-dose regimen with BNT162b2, CoronaVac or ChAdOx1-S in Brazil: differential neutralization of SARS-CoV-2 omicron variants. Clinical Immunology, 276, 12 . doi:10.1016/j.clim.2025.110492
NLM
Daher IP, Almeida B da S, Souza-Silva GA de, Marques RF, Soares GHC, Andreata-Santos R, Moretti A, Silva M de O, Schuch V, Sasahara GL, Kuramoto A, Yamamoto M, Santos K, Coelho VPC de V, Kalil Filho JE, Rosa DS, Cunha Neto E, Ferreira LC de S, Boscardin SB. Neutralizing antibody responses after a two-dose regimen with BNT162b2, CoronaVac or ChAdOx1-S in Brazil: differential neutralization of SARS-CoV-2 omicron variants [Internet]. Clinical Immunology. 2025 ; 276 12 .[citado 2025 jun. 26 ] Available from: https://doi.org/10.1016/j.clim.2025.110492
Vancouver
Daher IP, Almeida B da S, Souza-Silva GA de, Marques RF, Soares GHC, Andreata-Santos R, Moretti A, Silva M de O, Schuch V, Sasahara GL, Kuramoto A, Yamamoto M, Santos K, Coelho VPC de V, Kalil Filho JE, Rosa DS, Cunha Neto E, Ferreira LC de S, Boscardin SB. Neutralizing antibody responses after a two-dose regimen with BNT162b2, CoronaVac or ChAdOx1-S in Brazil: differential neutralization of SARS-CoV-2 omicron variants [Internet]. Clinical Immunology. 2025 ; 276 12 .[citado 2025 jun. 26 ] Available from: https://doi.org/10.1016/j.clim.2025.110492
Artigo de periodico
Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein (2024)
Silva, Mariângela de Oliveira ; Castro-Amarante, Maria Fernanda ; Carvalho, Alexia Adrianne Venceslau Brito ; Almeida, Bianca da Silva; Daher, Isabela Pazotti ; Souza-Silva, Guilherme Antonio de ; Yamamoto, Marcio Massao ; Koike, Gabriela ; Souza, Edmarcia Elisa de ; Wrenger, Carsten ; Ferreira, Luis Carlos de Souza ; Boscardin, Silvia Beatriz
Fonte: Vaccines. Unidades: ICB, FM
Assuntos: PARASITOLOGIA, MICROBIOLOGIA, PROTEÍNAS RECOMBINANTES, PROTEÍNAS SANGUÍNEAS, ANTICORPOS, IMUNOGENICIDADE DA VACINA, IMUNOGENÉTICA, IMUNOGLOBULINAS, COVID-19, VACINAS VIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Mariângela de Oliveira et al. Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein. Vaccines, v. 12, n. 4, p. 14 , 2024Tradução . . Disponível em: https://doi.org/10.3390/vaccines12040356. Acesso em: 26 jun. 2025.
APA
Silva, M. de O., Castro-Amarante, M. F., Carvalho, A. A. V. B., Almeida, B. da S., Daher, I. P., Souza-Silva, G. A. de, et al. (2024). Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein. Vaccines, 12( 4), 14 . doi:10.3390/vaccines12040356
NLM
Silva M de O, Castro-Amarante MF, Carvalho AAVB, Almeida B da S, Daher IP, Souza-Silva GA de, Yamamoto MM, Koike G, Souza EE de, Wrenger C, Ferreira LC de S, Boscardin SB. Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein [Internet]. Vaccines. 2024 ; 12( 4): 14 .[citado 2025 jun. 26 ] Available from: https://doi.org/10.3390/vaccines12040356
Vancouver
Silva M de O, Castro-Amarante MF, Carvalho AAVB, Almeida B da S, Daher IP, Souza-Silva GA de, Yamamoto MM, Koike G, Souza EE de, Wrenger C, Ferreira LC de S, Boscardin SB. Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein [Internet]. Vaccines. 2024 ; 12( 4): 14 .[citado 2025 jun. 26 ] Available from: https://doi.org/10.3390/vaccines12040356
Artigo de periodico
Anti-RBD IgG antibodies from endemic coronaviruses do not protect against the acquisition of SARS-CoV-2 infection among exposed uninfected individuals (2024)
Adami, Flávia Lopes ; Castro, Mateus Vidigal de ; Almeida, Bianca da Silva ; Daher, Isabela Pazotti ; Yamamoto, Marcio Massao ; Santos, Keity Souza ; Zatz, Mayana ; Naslavsky, Michel Satya ; Rosa, Daniela Santoro ; Cunha Neto, Edecio ; Oliveira, Vivian Leite de ; Kalil Filho, Jorge Elias ; Boscardin, Silvia Beatriz
Fonte: Frontiers in Immunology. Unidades: ICB, FM, IB
Assuntos: PARASITOLOGIA, ANTIVIRAIS, COVID-19, CORONAVIRUS, INFECÇÕES POR CORONAVIRUS, IMUNOGLOBULINAS, GLICOPROTEÍNAS, ESTUDOS DE COORTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ADAMI, Flávia Lopes et al. Anti-RBD IgG antibodies from endemic coronaviruses do not protect against the acquisition of SARS-CoV-2 infection among exposed uninfected individuals. Frontiers in Immunology, v. 15, p. 10 , 2024Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2024.1396603. Acesso em: 26 jun. 2025.
APA
Adami, F. L., Castro, M. V. de, Almeida, B. da S., Daher, I. P., Yamamoto, M. M., Santos, K. S., et al. (2024). Anti-RBD IgG antibodies from endemic coronaviruses do not protect against the acquisition of SARS-CoV-2 infection among exposed uninfected individuals. Frontiers in Immunology, 15, 10 . doi:10.3389/fimmu.2024.1396603
NLM
Adami FL, Castro MV de, Almeida B da S, Daher IP, Yamamoto MM, Santos KS, Zatz M, Naslavsky MS, Rosa DS, Cunha Neto E, Oliveira VL de, Kalil Filho JE, Boscardin SB. Anti-RBD IgG antibodies from endemic coronaviruses do not protect against the acquisition of SARS-CoV-2 infection among exposed uninfected individuals [Internet]. Frontiers in Immunology. 2024 ; 15 10 .[citado 2025 jun. 26 ] Available from: https://doi.org/10.3389/fimmu.2024.1396603
Vancouver
Adami FL, Castro MV de, Almeida B da S, Daher IP, Yamamoto MM, Santos KS, Zatz M, Naslavsky MS, Rosa DS, Cunha Neto E, Oliveira VL de, Kalil Filho JE, Boscardin SB. Anti-RBD IgG antibodies from endemic coronaviruses do not protect against the acquisition of SARS-CoV-2 infection among exposed uninfected individuals [Internet]. Frontiers in Immunology. 2024 ; 15 10 .[citado 2025 jun. 26 ] Available from: https://doi.org/10.3389/fimmu.2024.1396603
Trabalho de evento-resumo
Comparison between epitope prediction and vaccination of bovines immunized with recombinant proteins of Rhipicephalus microplus tick saliva (2018)
Almeida, Luiz Gustavo Nogueira de; Fisch, Andressa; Daher, Isabela Pazotti; Nascimento, Mariana Oliveira; Pupin, Maria Amélia Ferrão; Moraes, Alexsander de; Peña, Mauricio Scavassini; Ferreira, Beatriz Rossetti ; Santos, Isabel Kinney Ferreira de Miranda
Fonte: Abstract Book. Nome do evento: Congress of the Brazilian Society of Immunology. Unidades: FMRP, EERP
Assuntos: VACINAS, IMUNOLOGIA, EPITOPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALMEIDA, Luiz Gustavo Nogueira de et al. Comparison between epitope prediction and vaccination of bovines immunized with recombinant proteins of Rhipicephalus microplus tick saliva. 2018, Anais.. Ouro Preto: SBI, 2018. Disponível em: http://itarget.com.br/newclients/sbi2018/wp-content/uploads/2019/01/LIVRO-COMPLETO-IMMUNO-2018.pdf. Acesso em: 26 jun. 2025.
APA
Almeida, L. G. N. de, Fisch, A., Daher, I. P., Nascimento, M. O., Pupin, M. A. F., Moraes, A. de, et al. (2018). Comparison between epitope prediction and vaccination of bovines immunized with recombinant proteins of Rhipicephalus microplus tick saliva. In Abstract Book. Ouro Preto: SBI. Recuperado de http://itarget.com.br/newclients/sbi2018/wp-content/uploads/2019/01/LIVRO-COMPLETO-IMMUNO-2018.pdf
NLM
Almeida LGN de, Fisch A, Daher IP, Nascimento MO, Pupin MAF, Moraes A de, Peña MS, Ferreira BR, Santos IKF de M. Comparison between epitope prediction and vaccination of bovines immunized with recombinant proteins of Rhipicephalus microplus tick saliva [Internet]. Abstract Book. 2018 ;[citado 2025 jun. 26 ] Available from: http://itarget.com.br/newclients/sbi2018/wp-content/uploads/2019/01/LIVRO-COMPLETO-IMMUNO-2018.pdf
Vancouver
Almeida LGN de, Fisch A, Daher IP, Nascimento MO, Pupin MAF, Moraes A de, Peña MS, Ferreira BR, Santos IKF de M. Comparison between epitope prediction and vaccination of bovines immunized with recombinant proteins of Rhipicephalus microplus tick saliva [Internet]. Abstract Book. 2018 ;[citado 2025 jun. 26 ] Available from: http://itarget.com.br/newclients/sbi2018/wp-content/uploads/2019/01/LIVRO-COMPLETO-IMMUNO-2018.pdf
Trabalho de evento-resumo
Heterologous production of salivary protein from the cattle tick in Pichia pastoris: expression and purification of the vaccine antigen Rm2067 (2018)
Moraes, Alexsander de; Montoya, Bogar Omar Araujo; Peña, Mauricio Scavassini; Fisch, Andressa; Pupin, Maria Amélia Ferrão; Petta, Tânia; Almeida, Luiz Gustavo Nogueira de; Daher, Isabela Pazotti; Nascimento, Mariana Oliveira; Santos, Isabel Kinney Ferreira de Miranda; Ferreira, Beatriz Rossetti
Fonte: Abstract Book. Nome do evento: Congress of the Brazilian Society of Immunology. Unidades: FMRP, EERP
Assuntos: VACINAS, IMUNOLOGIA, GADO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORAES, Alexsander de et al. Heterologous production of salivary protein from the cattle tick in Pichia pastoris: expression and purification of the vaccine antigen Rm2067. 2018, Anais.. Ouro Preto: SBI, 2018. Disponível em: http://itarget.com.br/newclients/sbi2018/wp-content/uploads/2019/01/LIVRO-COMPLETO-IMMUNO-2018.pdf. Acesso em: 26 jun. 2025.
APA
Moraes, A. de, Montoya, B. O. A., Peña, M. S., Fisch, A., Pupin, M. A. F., Petta, T., et al. (2018). Heterologous production of salivary protein from the cattle tick in Pichia pastoris: expression and purification of the vaccine antigen Rm2067. In Abstract Book. Ouro Preto: SBI. Recuperado de http://itarget.com.br/newclients/sbi2018/wp-content/uploads/2019/01/LIVRO-COMPLETO-IMMUNO-2018.pdf
NLM
Moraes A de, Montoya BOA, Peña MS, Fisch A, Pupin MAF, Petta T, Almeida LGN de, Daher IP, Nascimento MO, Santos IKF de M, Ferreira BR. Heterologous production of salivary protein from the cattle tick in Pichia pastoris: expression and purification of the vaccine antigen Rm2067 [Internet]. Abstract Book. 2018 ;[citado 2025 jun. 26 ] Available from: http://itarget.com.br/newclients/sbi2018/wp-content/uploads/2019/01/LIVRO-COMPLETO-IMMUNO-2018.pdf
Vancouver
Moraes A de, Montoya BOA, Peña MS, Fisch A, Pupin MAF, Petta T, Almeida LGN de, Daher IP, Nascimento MO, Santos IKF de M, Ferreira BR. Heterologous production of salivary protein from the cattle tick in Pichia pastoris: expression and purification of the vaccine antigen Rm2067 [Internet]. Abstract Book. 2018 ;[citado 2025 jun. 26 ] Available from: http://itarget.com.br/newclients/sbi2018/wp-content/uploads/2019/01/LIVRO-COMPLETO-IMMUNO-2018.pdf

Unidades USP

ReP

Filtros

Unidades USP

Departamento

Autores

Autores USP

Assuntos

Agência de fomento